Healthcare -
Biotechnology - NASDAQ - US
$ 1.755
1.45 %
$ 267 M
Market Cap
-10.97
P/E
HRTX - OPERATING EXPENSES
Operating Expenses HRTX - Heron Therapeutics, Inc.
173 M
LAST VALUE
-18.24%
2 YEAR CAGR
-5.90%
5 YEAR CAGR
12.22%
10 YEAR CAGR